Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ: REGN · Real-Time Price · USD
957.76
+5.36 (0.56%)
At close: Nov 17, 2026, 4:00 PM EST
965.00
+7.24 (0.76%)
After-hours: Nov 17, 2026, 6:14 PM EST
Regeneron Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $917 → $1,075 | Buy | Maintains | $917 → $1,075 | +12.24% | Nov 17, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $1,175 | Buy | Maintains | $1,175 | +22.68% | Nov 11, 2026 |
| Citi | Citi | Hold Maintains $825 | Hold | Maintains | $825 | -13.86% | Nov 11, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $1,030 | Buy | Maintains | $1,030 | +7.54% | Nov 11, 2026 |
| BMO Capital | BMO Capital | Buy Maintains $920 → $1,050 | Buy | Maintains | $920 → $1,050 | +9.63% | Nov 3, 2026 |
| Leerink Partners | Leerink Partners | Hold Maintains $835 → $997 | Hold | Maintains | $835 → $997 | +4.10% | Nov 2, 2026 |
| UBS | UBS | Buy Maintains $978 → $1,068 | Buy | Maintains | $978 → $1,068 | +11.51% | Nov 2, 2026 |
| Bernstein | Bernstein | Hold Maintains $756 → $812 | Hold | Maintains | $756 → $812 | -15.22% | Nov 2, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.